The FDA, amid growing concerns about the risk of uncontrolled bleeding when taking Pradaxa, has determined that an additional comprehensive study of the drug is necessary to determine its safety in comparison with warfarin. See FDA’s statement at the following.
Pradaxa to undergo new FDA safety study
TALK TO US
Have questions about your situation?
Contact Nidel & Nace for a free, confidential consultation with an attorney.
REQUEST A CONSULTATIONCALL 202-780-5153This post is for informational purposes only and is not legal or medical advice. Prior results do not guarantee a similar outcome.
ABOUT THE AUTHORChris Nidel
Chris Nidel is the founding partner of Nidel & Nace. A chemical engineer by training (University of Virginia and MIT), he worked in pharmaceutical process development before earning his law degree at the University of Virginia. He now represents individuals and communities harmed by environmental contamination and toxic exposures.
View full profile
ABOUT THE AUTHORJonathan Nace
Jonathan Nace is a partner at Nidel & Nace, where his practice focuses on complex consumer protection, including deceptive food and supplement labeling, insurance misconduct, and data privacy. He has tried cases in state and federal court and argued before federal appellate courts.
View full profile
ABOUT THE AUTHORZachary Kelsay
Zachary Kelsay is an attorney at Nidel & Nace supporting the firm’s environmental and consumer protection practices. He previously clerked for the 23rd Circuit Court in West Virginia and worked in the Maryland Attorney General’s Consumer Protection Division.
View full profileFree, confidential case review
Tell us what happened. An attorney will review it and get back to you.
START MY CASE REVIEW202-780-5153